Version 5.4
Bos taurus Protein: FAM123B
Summary
InnateDB Protein IDBP-700044.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol FAM123B
Protein Name family with sequence similarity 123B
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000011639
InnateDB Gene IDBG-647200 (FAM123B)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 6 interaction(s) predicted by orthology.
Predicted by orthology
Total 6 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
GO:0005546 phosphatidylinositol-4,5-bisphosphate binding
GO:0008013 beta-catenin binding
Biological Process
GO:0001822 kidney development
GO:0060348 bone development
GO:0060612 adipose tissue development
GO:0060828 regulation of canonical Wnt signaling pathway
GO:0072161 mesenchymal cell differentiation involved in kidney development
GO:0090090 negative regulation of canonical Wnt signaling pathway
GO:0090263 positive regulation of canonical Wnt signaling pathway
Cellular Component
GO:0005886 plasma membrane
Protein Structure and Domains
PDB ID
InterPro IPR019003 Uncharacterised protein family FAM123
PFAM PF09422
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E1BL05
UniProt Splice Variant
Entrez Gene 539029
UniGene Bt.88845
RefSeq XP_002700216
HUGO HGNC:26837
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02073449
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca